Targeting the Mechanisms Underlying Cutaneous Neurofibroma Formation in NF1: A Clinical Translational Approach.

CompletedOBSERVATIONAL
Enrollment

71

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Cutaneous NeurofibromasNeurofibromatosis Type 1Plexiform Neurofibromas
Interventions
PROCEDURE

Skin Biopsy

"The procedure to sample the cutaneous neurofibroma involves a skin incision and will take approximately 10 to 15 minutes. The tissue will be taken in the following way:~* The skin area will be cleaned~* The skin area will be numbed (by either a numbing cream or a tiny numbing shot)~* Cutaneous (skin) Neurofibroma: will be taken via a small incision and removal of the neurofibroma whenever possible.~* A small piece of normal (skin) tissue will be numbed as above and taken using a special skin biopsy device.~Afterward, the area will be cleaned and the skin put back together with medical super glue or 1 to 2 dissolvable stitches that will dissolve as the incision heals, they do not require removal. The purpose of taking this piece of skin is to compare normal skin with the skin of a cutaneous neurofibroma."

Trial Locations (1)

49503

Spectrum Health Hospital Group, Grand Rapids

All Listed Sponsors
collaborator

Van Andel Research Institute

OTHER

lead

Spectrum Health Hospitals

OTHER

NCT02777775 - Targeting the Mechanisms Underlying Cutaneous Neurofibroma Formation in NF1: A Clinical Translational Approach. | Biotech Hunter | Biotech Hunter